Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Kiniksa Pharmaceuticals International (KNSA) Leases (2021 - 2025)

Historic Leases for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $10.1 million.

  • Kiniksa Pharmaceuticals International's Leases fell 921.14% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 921.14%. This contributed to the annual value of $10.4 million for FY2024, which is 1303.33% down from last year.
  • Kiniksa Pharmaceuticals International's Leases amounted to $10.1 million in Q3 2025, which was down 921.14% from $10.3 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Leases ranged from a high of $13.2 million in Q2 2023 and a low of $4.1 million during Q2 2022
  • Its 5-year average for Leases is $8.6 million, with a median of $10.1 million in 2025.
  • Its Leases has fluctuated over the past 5 years, first crashed by 2445.23% in 2022, then soared by 22418.28% in 2023.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Leases stood at $5.6 million in 2021, then decreased by 2.97% to $5.4 million in 2022, then surged by 121.56% to $11.9 million in 2023, then fell by 13.03% to $10.4 million in 2024, then dropped by 2.92% to $10.1 million in 2025.
  • Its Leases stands at $10.1 million for Q3 2025, versus $10.3 million for Q2 2025 and $10.5 million for Q1 2025.